China · Biotechnology Research
Research
Pharmaceuticals
Biotechnology
Health Care
Biotechnology Research
Jacobio Pharma (1167.HK) is committed to developing and providing new and innovative products and solutions to improve people's health. Our pipeline revolves around novel molecular targets on six major signalling pathways: KRAS, immune checkpoints, tumor metabolism, P53, RB and MYC. We aim for our key projects to be among the top three in the world. Our vision is to become a global leader recognized for our impact in drug R&D together with our partners. Jacobio has R&D centers in Beijing, Shanghai and Boston with our Induced Allosteric Drug Discovery Platform (IADDP) and our iADC Platform.
2015
Founded
Biotechnology Research
Industry
China
Location
2,930,486
Ranking
42 employees
Size

Get full access to view complete information
